Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-573.08%
operating margin TTM
-337.23%
revenue TTM
100.86 Thousand
revenue per share TTM
0.0$
valuation ratios | |
|---|---|
| pe ratio | -6.25 |
| peg ratio | -2.63 |
| price to book ratio | -4.19 |
| price to sales ratio | 37.13 |
| enterprise value multiple | -8.41 |
| price fair value | -4.19 |
profitability ratios | |
|---|---|
| gross profit margin | 64.0% |
| operating profit margin | -337.23% |
| pretax profit margin | -471.23% |
| net profit margin | -573.08% |
| return on assets | -311.72% |
| return on equity | 65.96% |
| return on capital employed | 44.07% |
liquidity ratios | |
|---|---|
| current ratio | 0.09 |
| quick ratio | 0.00 |
| cash ratio | 0.00 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 779.91 |
| operating cycle | 782.16 |
| days of payables outstanding | 3,710.83 |
| cash conversion cycle | -2,928.67 |
| receivables turnover | 162.50 |
| payables turnover | 0.10 |
| inventory turnover | 0.47 |
debt and solvency ratios | |
|---|---|
| debt ratio | 2.33 |
| debt equity ratio | -0.48 |
| long term debt to capitalization | -0.03 |
| total debt to capitalization | -0.94 |
| interest coverage | -3.65 |
| cash flow to debt ratio | -0.54 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.02 |
| cash per share | 0.00 |
| operating cash flow per share | -0.02 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -0.54 |
| short term coverage ratios | -0.78 |
| capital expenditure coverage ratio | -752.00 |
Frequently Asked Questions
When was the last time Guided Therapeutics, Inc. (PNK:GTHP) reported earnings?
Guided Therapeutics, Inc. (GTHP) published its most recent earnings results on 13-08-2026.
What is Guided Therapeutics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Guided Therapeutics, Inc. (PNK:GTHP)'s trailing twelve months ROE is 65.96%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Guided Therapeutics, Inc. (GTHP) currently has a ROA of -311.72%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did GTHP's net profit margin stand at?
GTHP reported a profit margin of -573.08% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is GTHP's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 0.09 in the most recent quarter. The quick ratio stood at 0.00, with a Debt/Eq ratio of -0.48.